ClinicalTrials.gov
ClinicalTrials.gov Menu

FLuctuATion Reduction With inSULin and Glp-1 Added togetheR (FLAT-SUGAR) (FLAT-SUGAR)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01524705
Recruitment Status : Completed
First Posted : February 2, 2012
Last Update Posted : September 18, 2014
Sponsor:
Collaborators:
Eli Lilly and Company
Sanofi
Bristol-Myers-Squibb/Astra-Zeneca
DexCom, Inc.
Bayer
Becton, Dickinson and Company
Medicomp
University of Texas
VA Office of Research and Development
Biomedical Research Institute of New Mexico
Information provided by (Responsible Party):
Jeff Probstfield, University of Washington

Results Submitted - Not Posted on ClinicalTrials.gov
Results information has been submitted to ClinicalTrials.gov by the sponsor or investigator, but is not yet publicly available (or "posted") on ClinicalTrials.gov. The submitted information may not be available if it is pending Quality Control (QC) Review by the National Library of Medicine (NLM) or if issues identified during QC review are being addressed or corrected by the sponsor or investigator. NLM's limited QC review assesses for apparent errors, deficiencies, or inconsistencies. NLM staff do not verify the scientific validity or relevance of the submitted information.
  Recruitment Status : Completed
  Actual Primary Completion Date : July 2014
  Actual Study Completion Date : July 2014

Submission Cycle Results Submitted to ClinicalTrials.gov Results Returned after Quality Control Review
1 April 21, 2017  
2 April 24, 2017 May 31, 2017
3 October 12, 2017 November 13, 2017
Publications:

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):